rs144657355

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000075.4(CDK4):​c.764G>A​(p.Arg255His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R255C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000065 ( 0 hom. )

Consequence

CDK4
NM_000075.4 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:7

Conservation

PhyloP100: 1.62

Publications

5 publications found
Variant links:
Genes affected
CDK4 (HGNC:1773): (cyclin dependent kinase 4) The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq, Jul 2008]
TSPAN31 (HGNC:10539): (tetraspanin 31) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is thought to be involved in growth-related cellular processes. This gene is associated with tumorigenesis and osteosarcoma. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.044970125).
BP6
Variant 12-57749237-C-T is Benign according to our data. Variant chr12-57749237-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 184333.
BS2
High AC in GnomAd4 at 57 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000075.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDK4
NM_000075.4
MANE Select
c.764G>Ap.Arg255His
missense
Exon 7 of 8NP_000066.1P11802-1
TSPAN31
NM_005981.5
MANE Select
c.*1947C>T
3_prime_UTR
Exon 6 of 6NP_005972.1Q12999
TSPAN31
NM_001330169.2
c.*1947C>T
3_prime_UTR
Exon 6 of 6NP_001317098.1B4DFJ7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDK4
ENST00000257904.11
TSL:1 MANE Select
c.764G>Ap.Arg255His
missense
Exon 7 of 8ENSP00000257904.5P11802-1
TSPAN31
ENST00000257910.8
TSL:1 MANE Select
c.*1947C>T
3_prime_UTR
Exon 6 of 6ENSP00000257910.3Q12999
TSPAN31
ENST00000547992.5
TSL:1
c.*1947C>T
3_prime_UTR
Exon 4 of 4ENSP00000448209.1F8VS78

Frequencies

GnomAD3 genomes
AF:
0.000375
AC:
57
AN:
152194
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000172
AC:
43
AN:
250544
AF XY:
0.000155
show subpopulations
Gnomad AFR exome
AF:
0.00107
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000693
Gnomad NFE exome
AF:
0.0000529
Gnomad OTH exome
AF:
0.000492
GnomAD4 exome
AF:
0.0000650
AC:
95
AN:
1461726
Hom.:
0
Cov.:
32
AF XY:
0.0000688
AC XY:
50
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33476
American (AMR)
AF:
0.0000447
AC:
2
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86250
European-Finnish (FIN)
AF:
0.000599
AC:
32
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111882
Other (OTH)
AF:
0.000116
AC:
7
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000374
AC:
57
AN:
152312
Hom.:
0
Cov.:
32
AF XY:
0.000376
AC XY:
28
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41578
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000269
Hom.:
0
Bravo
AF:
0.000340
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000165
AC:
20

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
2
-
Melanoma, cutaneous malignant, susceptibility to, 3 (2)
-
-
2
not provided (2)
-
1
1
not specified (2)
-
-
1
CDK4-related disorder (1)
-
-
1
Familial melanoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.20
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.48
T
Eigen
Benign
-0.079
Eigen_PC
Benign
0.095
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.045
T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
1.9
L
PhyloP100
1.6
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.11
Sift
Uncertain
0.011
D
Sift4G
Benign
0.13
T
Polyphen
0.0040
B
Vest4
0.32
MVP
0.80
MPC
0.77
ClinPred
0.027
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.39
gMVP
0.57
Mutation Taster
=73/27
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144657355; hg19: chr12-58143020; COSMIC: COSV57276122; COSMIC: COSV57276122; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.